Regulatory experts
- 8fold Governance
- Acorn Compliance
- AI Centre for Value-Based Healthcare
- Assuric Compliance
- Blüm Health
- Brunel University of London
- Guy's and St Thomas' NHS Foundation Trust
- Hardian Health
The DigitalHealth.London RADIANT-CERSI Innovator Support programme is designed to improve understanding of the regulatory landscape and compliance process for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD). Its key goal is to support valuable UK medical innovations to reach the market safely and efficiently.
RADIANT-CERSI is one of seven Centre of Excellence in Regulatory Science and Innovation (CERSI) in Transformative Digital Health and AI across the UK. It is funded by Innovate UK, in partnership with the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Office for Life Sciences (OLS).
It is led by Brunel University of London, with partners across healthcare, research and academia, including the Health Innovation Network South London, Helix Data Innovation, Zinc, UCL, Imperial College Healthcare NHS Trust, King's College London and BMJ.

DigitalHealth.London forms part of RADIANT-CERSI's advisory board, alongside Osborne Clarke, University of Cambridge, NIHR HealthTech Research Centre, Department for Business and Trade, Association of British HealthTech Industries (ABHI), NIHR Applied Research Collaborative, GSK and National Institute for Health and Care Excellence (NICE).
RADIANT-CERSI is on a mission to bridge the gap between regulatory science and real-world innovation. By streamlining access to timely regulation, the network aims to foster a business-friendly, evidence-based and sustainable regulatory environment. This will support the safe and efficient development of AI and digital health technologies, shaping the future of healthcare and enabling continued growth in the sector.
The programme was delivered between May 2025 and November 2025. As part of RADIANT-CERSI, the Health Innovation Network South London and DigitalHealth.London delivered an online innovator support programme this summer. This series of nine online workshops supported 65 digital health companies in navigating current regulatory requirements for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD), with topics including regulatory frameworks, clinical evaluation, and quality management.
Sessions from regulatory bodies helped improve understanding on how to navigate current regulatory requirements for SaMD and AIaMD.
Subject matters experts provided knowledge and guidance on how to direct the development and evaluation of digital health solutions.
Resource offered information and practical advice on how to plan regulatory compliance activities.
Providing a forum for identifying challenges and risks associated with the development of AI in healthcare and facilitating opportunities to hear from peers, experts and stakeholders.
Ongoing network provided regulatory guidance, enabling access to additional resources and networking opportunities within the broader RADIANT-CERSI network.
Participants left with more than just enhanced regulatory knowledge; they gained structured pathways for progressing regulatory activities and greater confidence in navigating complex requirements. The collaborative nature of the programme also fostered lasting peer connections, creating a network for continued shared learning.
Noteworthy outcomes:
Net promoter category
Agreed the programme was appropriate for their stage of the regulatory journey
Said they have or will change their approach to regulatory compliance as a result of the programme
*of participants surveyed
The session [on quality management systems] opened our eyes to QMS approach for compliance. We know how expensive and timely it is to find a QMS. The advice was HUGE in terms of value, and we have utilised this and started to implement it, which will help us in so many different aspects of our medical device journey.” Particpant
"Today’s session was quite revealing, there is a limit to how much the regulatory consultants can tell us. But actual businesses or organisaitons going through the process shows us how it’s done from a first-person perspective." Particpant
We got to hear from first cohort of the programme, MedForce AI, Omnilabs Research and Suna Health share how the knowledge gained has gone on to shape value propositions, professional growth and business development.
Case studies of the programme's impact on these companies can be found below.

MedForce AI develops specialist diagnostic GenAI products designed to reduce waiting lists and prevent adverse events.
Jay Liu, CEO and founder of MedForce AI, shares how the programme boosted their confidence and deepened their knowledge of regulatory pathways.

Omnihuman VR is a personalised telerehabilitation tool designed to support stroke survivors by improving adherence to exercises.
Lucie Legrandois, Co-founder of Omnilabs Research, shares how the programme provided valuable access to a network of peers and professionals, with expert-led sessions, practical insights and tools that helped kick-start their regulatory journey.

Suna Health's wearable patch uses AI-powered acoustic detection to continuously monitor gastrointestinal activity.
Dr Chad Okay, Founder of Suna Health and NHS GP resident, shares how the programme transformed regulation from a “black box” into a strategic process, helping the company to plan for future growth.
Learn more about the programme’s design and how key learnings from the programme will shape the future of regulation.
Read moreApplications are now closed for the DigitalHealth.London RADIANT-CERSI Innovator Support Programme. Click the button below to find out more about the latest opportunities from RADIANT-CERSI.
Find out more